期刊文献+

Emerging targets in cancer drug resistance 被引量:4

原文传递
导出
摘要 Drug resistance is a complex phenomenon that frequently develops as a failure to chemotherapy during cancer treatment.Malignant cells increasingly generate resistance to various chemotherapeutic drugs through distinct mechanisms and pathways.Understanding the molecular mechanisms involved in drug resistance remains an important area of research for identification of precise targets and drug discovery to improve therapeutic outcomes.This review highlights the role of some recent emerging targets and pathways which play critical role in driving drug resistance.
出处 《Cancer Drug Resistance》 2019年第2期161-177,共17页 癌症耐药(英文)
基金 Efforts are supported by the Department of Defense Grants(W81XWH-18-1-0618,W81XWH-15-1-0558) VA Merit Review(1I01BX002494)to Gupta S.Kushwaha PP acknowledges financial support from University Grants Commission,India in the form of CSIR-UGC Senior Research fellowship Kumar S acknowledges Department of Science and Technology,India,and University Grants Commission,India for providing financial support in the form of DST-SERB Grant[EEQ/2016/000350]and UGC-BSR Research Start-Up-Grant[No.F.30-372/2017(BSR)]respectively.
  • 相关文献

参考文献1

二级参考文献69

  • 1Shariat SF, Andrews B, Kattan MW, Kim J, Wheeler TM, Slawin KM. Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. Urology 2001;58: 1008-15.
  • 2Harbour, JW, Dean DC. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev 2000;14: 2393-409.
  • 3Dimova DK, Dyson NJ. The E2F transcriptional network: old acquaintances with new faces. Oncogene 2005;24: 2810-26.
  • 4Hunt KK, Keyomarsi K. Cyclin E as a prognostic and predictive marker in breast cancer. Semin Cancer Biol 2005;15: 319-26.
  • 5Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y,Hortobagyi GN, et al. Cyclin E and survival in patients with breast cancer. N Engl J Med 2002;347: 1566-75.
  • 6Han S, Park K, Bae BN, Kim KH, Kim HJ, Kim YD, et al. E2F1 expression is related with the poor survival of lymph node-positive breast cancer patients treated with fluorouracil, doxorubicin and cyclophosphamide. Breast Cancer Res Treat 2003;82:11-6.
  • 7Dhillon NK, Mudryj M. Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest. Oncogene 2002;21: 4626-34.
  • 8Grimberg A. Mechanisms by which IGF-I may promote cancer.Cancer Biol Ther 2003;2: 630-5.
  • 9Oh A, List H J, Reiter R, Mani A, Zhang Y, Gehan E, et al. The nuclear receptor coactivator AIB 1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells.Cancer Res 2004;64: 8299-308.
  • 10Zhou G, Hashimoto Y, Kwak I, Tsai SY, Tsai MJ. Role of the steroid receptor coactivator SRC-3 in cell growth. Mol Cell Biol 2003;23:7742-55.

共引文献12

同被引文献16

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部